Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays

Crimean-Congo haemorrhagic fever virus (CCHFV) is a pathogen of increasing public health concern, being a widely distributed arbovirus and the causative agent of the potentially fatal Crimean-Congo haemorrhagic fever. Hazara virus (HAZV) is a genetically and serologically related virus that has been proposed as a surrogate for antiviral and vaccine testing for CCHFV. Glycosylation analysis of HAZV has been limited; first, we confirmed for the first time the occupation of two N-glycosylation sites in the HAZV glycoprotein. Despite this, there was no apparent antiviral efficacy of a panel of iminosugars against HAZV, as determined by quantification of the total secretion and infectious virus titres produced following infection of SW13 and Vero cells. This lack of efficacy was not due to an inability of deoxynojirimycin (DNJ)-derivative iminosugars to access and inhibit endoplasmic reticulum α-glucosidases, as demonstrated by free oligosaccharide analysis in uninfected and infected SW13 and uninfected Vero cells. Even so, iminosugars may yet have potential as antivirals for CCHFV since the positions and importance of N-linked glycans may differ between the viruses, a hypothesis requiring further evaluation.

[1]  K. Spurgers,et al.  Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects , 2022, PLoS neglected tropical diseases.

[2]  N. Zitzmann,et al.  Antiviral effects of deoxynojirimycin (DNJ)-based iminosugars in dengue virus-infected primary dendritic cells , 2022, Antiviral research.

[3]  R. Dwek,et al.  Pathogen‐induced inflammation is attenuated by the iminosugar MON‐DNJ via modulation of the unfolded protein response , 2021, Immunology.

[4]  R. Dwek,et al.  Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike , 2021, ACS central science.

[5]  R. Dwek,et al.  Targeting ER α-glucosidase I with a single-dose iminosugar treatment protects against lethal influenza and dengue virus infections. , 2020, Journal of medicinal chemistry.

[6]  Z. Arab‐Bafrani,et al.  Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis. , 2019, The Journal of antimicrobial chemotherapy.

[7]  N. Zitzmann,et al.  Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus , 2019, Antiviral research.

[8]  T. Stockwell,et al.  Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B , 2019, Scientific Reports.

[9]  H. Feldmann,et al.  Favipiravir (T‐705) but not ribavirin is effective against two distinct strains of Crimean‐Congo hemorrhagic fever virus in mice , 2018, Antiviral research.

[10]  N. Zitzmann,et al.  Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus , 2018, Advances in experimental medicine and biology.

[11]  E. Punch,et al.  Potassium is a trigger for conformational change in the fusion spike of an enveloped RNA virus , 2018, The Journal of Biological Chemistry.

[12]  N. Zitzmann,et al.  Absolute quantitation of disease protein biomarkers in a single LC-MS acquisition using apolipoprotein F as an example , 2017, Scientific Reports.

[13]  S. Mohammed,et al.  Interdomain conformational flexibility underpins the activity of UGGT, the eukaryotic glycoprotein secretion checkpoint , 2017, Proceedings of the National Academy of Sciences.

[14]  N. Maayan,et al.  Ribavirin for treating Crimean Congo haemorrhagic fever , 2017, The Cochrane database of systematic reviews.

[15]  R. Dwek,et al.  Iminosugar antivirals: the therapeutic sweet spot , 2017, Biochemical Society transactions.

[16]  N. Zitzmann,et al.  Iminosugars: Promising therapeutics for influenza infection , 2016, Critical reviews in microbiology.

[17]  T. Edwards,et al.  Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle , 2016, Journal of Virology.

[18]  H. Guzmán,et al.  Genomic Characterization of the Genus Nairovirus (Family Bunyaviridae) , 2016, Viruses.

[19]  R. Dwek,et al.  Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4 , 2016, Antiviral research.

[20]  C. Spiropoulou,et al.  Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus , 2016, Viruses.

[21]  S. Vasudevan,et al.  Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy. , 2016, Antiviral research.

[22]  R. Dwek,et al.  Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases—Not Glycolipid Processing Enzymes , 2016, PLoS neglected tropical diseases.

[23]  T. Nabeshima,et al.  Tofla virus: A newly identified Nairovirus of the Crimean-Congo hemorrhagic fever group isolated from ticks in Japan , 2016, Scientific Reports.

[24]  F. Weber,et al.  Meeting report: First International Conference on Crimean-Congo hemorrhagic fever. , 2015, Antiviral research.

[25]  Dylan B. George,et al.  The global distribution of Crimean-Congo hemorrhagic fever , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  S. Günther,et al.  Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever , 2014, PLoS neglected tropical diseases.

[27]  Gajendra P. S. Raghava,et al.  In silico Platform for Prediction of N-, O- and C-Glycosites in Eukaryotic Protein Sequences , 2013, PloS one.

[28]  R. Hewson,et al.  Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus. , 2012, The Journal of general virology.

[29]  K. Chan,et al.  Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. , 2011, The Journal of antimicrobial chemotherapy.

[30]  C. Peyrefitte,et al.  Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin , 2011, Virology Journal.

[31]  J. Alimonti,et al.  Pathogenesis and Immune Response of Crimean-Congo Hemorrhagic Fever Virus in a STAT-1 Knockout Mouse Model , 2010, Journal of Virology.

[32]  P. Garner,et al.  Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis , 2010, BMC infectious diseases.

[33]  M. McDowell,et al.  A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. , 2010, Antiviral research.

[34]  G. Yılmaz,et al.  The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[35]  S. Nichol,et al.  N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. , 2007, Virology.

[36]  T. Ksiazek,et al.  Crimean-Congo Hemorrhagic Fever Virus Genomics and Global Diversity , 2006, Journal of Virology.

[37]  S. Nichol,et al.  Crimean-Congo Hemorrhagic Fever Virus Glycoprotein Precursor Is Cleaved by Furin-Like and SKI-1 Proteases To Generate a Novel 38-Kilodalton Glycoprotein , 2006, Journal of Virology.

[38]  R. Doms,et al.  Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo , 2005, Journal of Virology.

[39]  R. Doms,et al.  Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins , 2005, Journal of Virology.

[40]  R. Dwek,et al.  Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis. , 2004, The Biochemical journal.

[41]  M. Bray,et al.  A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. , 2004, Antiviral research.

[42]  S. Nichol,et al.  Characterization of the Glycoproteins of Crimean-Congo Hemorrhagic Fever Virus , 2002, Journal of Virology.

[43]  Søren Brunak,et al.  Prediction of Glycosylation Across the Human Proteome and the Correlation to Protein Function , 2001, Pacific Symposium on Biocomputing.

[44]  P. Luan,et al.  Processing of viral envelope glycoprotein by the endomannosidase pathway: evaluation of host cell specificity. , 1998, Glycobiology.

[45]  H. Ploegh,et al.  Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharides. , 1994, Glycobiology.

[46]  R. Dwek,et al.  Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. H. Tignor,et al.  Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection , 1993, Antiviral Research.

[48]  C. Zurzolo,et al.  Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues , 1992, The Journal of cell biology.

[49]  D. Nash,et al.  Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. , 1989, The American journal of tropical medicine and hygiene.

[50]  A. Helenius,et al.  Interactions of misfolded influenza virus hemagglutinin with binding protein (BiP) , 1989, The Journal of cell biology.

[51]  S. Schlesinger,et al.  The formation of vesicular stomatitis virus (San Juan strain) becomes temperature-sensitive when glucose residues are retained on the oligosaccharides of the glycoprotein. , 1984, The Journal of biological chemistry.

[52]  G. R. French,et al.  Structural polypeptides of Hazara virus. , 1981, The Journal of general virology.

[53]  S. Buckley.  Cross Plaque Neutralization Tests with Cloned Crimean Hemorrhagic Fever-Congo (CHF-C) and Hazara Viruses 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[54]  C. Wisseman,et al.  Tick-borne viruses of West Pakistan. I. Isolation and general characteristics. , 1970, American journal of epidemiology.

[55]  C. Wisseman,et al.  Tick-borne viruses of West Pakistan. II. Hazara virus, a new agent isolated from Ixodes redikorzevi ticks from the Kaghan Valley, W. Pakistan. , 1970, American journal of epidemiology.

[56]  J. Casals,et al.  The Nairovirus genus: serological relationships. , 1980, Intervirology.